Literature DB >> 11992227

Practice effects on the WAIS-III across 3- and 6-month intervals.

Michael R Basso1, Francine D Carona, Natasha Lowery, Bradley N Axelrod.   

Abstract

Fifty-one participants (age M = 24.6; education M = 14.4 years) were administered the Wechsler Adult Intelligence Scale - Third Edition (WAIS-III) at baseline and at an interval of either 3 or 6 months later. Full Scale IQ (FSIQ), Verbal IQ (VIQ), Performance IQ (PIQ), Verbal Comprehension Index (VCI), Perceptual Organization Index (POI), and Processing Speed Index (PSI) scores improved significantly across time, whereas no significant change occurred on the Working Memory Index. Specifically, test scores increased approximately 3, 11, 6, 4, 8, and 7 points, respectively on the VIQ, PIQ, FSIQ, VCI, POI, and PSI for both groups. Notably, the degree of improvement was similar regardless of whether the inter-test interval was 3 or 6 months. These findings suggest that prior exposure to the WAIS-III yields considerable increases in test scores. Reliable change indices indicated that large confidence intervals might be expected. As such, users of the WAIS-III should interpret reevaluations across these intervals cautiously.

Entities:  

Mesh:

Year:  2002        PMID: 11992227     DOI: 10.1076/clin.16.1.57.8329

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  16 in total

1.  Assessment effects in educational and psychosocial intervention trials: an important but often-overlooked problem.

Authors:  Mi-Kyung Song; Sandra E Ward
Journal:  Res Nurs Health       Date:  2015-03-01       Impact factor: 2.228

2.  Four-year longitudinal performance of a population-based sample of healthy children on a neuropsychological battery: the NIH MRI study of normal brain development.

Authors:  Deborah P Waber; Peter W Forbes; C Robert Almli; Emily A Blood
Journal:  J Int Neuropsychol Soc       Date:  2012-03       Impact factor: 2.892

3.  Long-Term Treatment of Niemann-Pick Type C1 Disease With Intrathecal 2-Hydroxypropyl-β-Cyclodextrin.

Authors:  Elizabeth Berry-Kravis; Jamie Chin; Anne Hoffmann; Amy Winston; Robin Stoner; Lisa LaGorio; Katherine Friedmann; Mariana Hernandez; Daniel S Ory; Forbes D Porter; Joan A O'Keefe
Journal:  Pediatr Neurol       Date:  2018-01-08       Impact factor: 3.372

4.  Practice effects and amyloid deposition: preliminary data on a method for enriching samples in clinical trials.

Authors:  Kevin Duff; Norman L Foster; John M Hoffman
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jul-Sep       Impact factor: 2.703

5.  Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.

Authors:  Catherine M Bender; John D Merriman; Susan M Sereika; Amanda L Gentry; Frances E Casillo; Theresa A Koleck; Margaret Q Rosenzweig; Adam M Brufsky; Priscilla McAuliffe; Yehui Zhu; Yvette P Conley
Journal:  Oncol Nurs Forum       Date:  2018-05-01       Impact factor: 2.172

Review 6.  Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review.

Authors:  Jared L Moreines; Shawn M McClintock; Paul E Holtzheimer
Journal:  Brain Stimul       Date:  2010-02-11       Impact factor: 8.955

7.  Practice effect and normative data of an HIV-specific neuropsychological testing battery among healthy Thais.

Authors:  Pasiri Sithinamsuwan; Nicholas Hutchings; Jintanat Ananworanich; Lauren Wendelken; Putthachard Saengtawan; Robert Paul; Nitiya Chomchey; James L K Fletcher; Thep Chalermchai; Victor Valcour
Journal:  J Med Assoc Thai       Date:  2014-02

8.  Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change.

Authors:  Lucette A Cysique; Donald Franklin; Ian Abramson; Ronald J Ellis; Scott Letendre; Ann Collier; David Clifford; Benjamin Gelman; Justin McArthur; Susan Morgello; David Simpson; J Allen McCutchan; Igor Grant; Robert K Heaton
Journal:  J Clin Exp Neuropsychol       Date:  2011-03-07       Impact factor: 2.475

9.  Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy.

Authors:  L A Cysique; F Vaida; S Letendre; S Gibson; M Cherner; S P Woods; J A McCutchan; R K Heaton; R J Ellis
Journal:  Neurology       Date:  2009-05-27       Impact factor: 9.910

10.  The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts.

Authors:  Andrew J Levine; Charles H Hinkin; Eric N Miller; James T Becker; Ola A Selnes; Bruce A Cohen
Journal:  J Clin Exp Neuropsychol       Date:  2007-08       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.